Gleneagles Hospital Hong Kong marked the beginning of its local antimicrobial resistance (AMR) programme with a pledge to promote the responsible use of antibiotics and help raise public awareness of AMR.
Led by its CEO Dr Kenneth Tsang, the hospital departments showed their support by pledging to use antibiotics responsibly.
As part of IHH’s sustainability commitment to Care for Public, all IHH hospitals will implement antimicrobial resistance interventions in line with CDC, WHO and national guidelines by 2025.
Related Stories
Harnessing AI to Advance Patient-Centred Healthcare
Artificial intelligence is rapidly transforming healthcare, creating new opportunities to enhance patient care, improve clinical efficiency and accelerate medical innovation.
Supporting Women's Health Through Open Conversations
On 10 July, the Federation of Indian Chambers of Commerce & Industry Ladies Organisation (FICCI FLO), in partnership with Fortis Healthcare, hosted Menopause 360°: Body, Mind and Hormones, an initiative dedicated to raising awareness and encouraging open conversations around menopause.
IHH Laboratories D.N.A. Award
Discovery. Nurturing. Accuracy. The IHH Labs D.N.A. Award returns in 2026 to recognise medical technologists whose work forms a vital part of quality patient care.
.jpg?sfvrsn=21d67f46_1)
IHH Singapore Collaborates with Insurers to Improve Affordability of Private Hospital Care
People-led Innovation Driving Impact Across IHH Healthcare
Gleneagles Hospital Hong Kong Highlights Healthcare at ITB China 2026
Travel today is no longer defined by destinations alone — it is shaped by the confidence and assurance travellers carry with them.
